Stockscreener 앱 받기
51.64
0.88%
-0.46
시간 외 거래:
51.60
-0.04
-0.08%
Tempus Ai Inc 주식(TEM)의 최신 뉴스
Tempus AI Stock (TEM) Opinions on Recent AI Model Publications and Collaborations - Quiver Quantitative
Daily Brief Health Care: Aurora Cannabis , Tempus AI, Blue Water Vaccines, Suzhou Zelgen Biopharmaceuticals and more - Smartkarma
Daily Brief United States: Cracker Barrel Old Country, Gold, Tempus AI, Builders Firstsource, Mohawk Industries, Pbf Energy Inc Class A, RBC Bearings , Schneider National Inc, Smith (A.O.), Eastman Chemical Co and more - Smartkarma
Tempus AI Expands Cancer Platform With Launch of ArteraAI Prostate Test For Metastatic Patients - Stocktwits
Tempus AI, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
TEM to IDR: Tempus AI, Inc. • Robinhood Token Price in Indonesian Rupiah - CoinGecko
Tempus AI (TEM) CEO, Data, discloses 62,239-share bona fide stock gift - Stock Titan
Tempus Is Buying Cancer-Testing Partner Personalis for $1.5 Billion - RamaOnHealthcare
TEM to THB: Tempus AI, Inc. • Robinhood Token Price in Thai Baht - CoinGecko
TEM to CAD: Tempus AI, Inc. • Robinhood Token Price in Canadian Dollar - CoinGecko
TEM to BDT: Tempus AI, Inc. • Robinhood Token Price in Bangladeshi Taka - CoinGecko
Dimensional Fund Advisors LP Has $1.85 Million Stock Holdings in Tempus AI, Inc. $TEM - MarketBeat
TEM|Tempus AI Inc|Price:52.100|Chg%:-2.190 - tradingkey.com
TEM to SGD: Tempus AI, Inc. • Robinhood Token Price in Singapore Dollar - CoinGecko
TEM to EUR: Tempus AI, Inc. • Robinhood Token Price in Euro - CoinGecko
Tempus AI, Inc. • Robinhood Token Price History: Download TEM Historical Data - CoinGecko
Tempus AI, Inc. • Robinhood Token (TEM) Price, MarketCap, Charts and Fundamentals Info - BeInCrypto
Tempus AI's FDA Win Could Unlock Major Reimbursement Growth Ahead - Zacks Investment Research
Is Tempus AI Worth Buying as Growth Improves but Valuation Stays High? - The Globe and Mail
3 Stocks That May Be Trading Below Intrinsic Value Estimates By Up To 48.5% - simplywall.st
Tempus AI CEO, data Ryan Fukushima sells $1,000,800 in shares By Investing.com - Investing.com Australia
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells $1,000,800.00 in Stock - MarketBeat
Tempus AI Insider Sold Shares Worth $1,000,800, According to a Recent SEC Filing - Moomoo
Tempus AI CEO, data Ryan Fukushima sells $1,000,800 in shares - Investing.com
Tempus AI (TEM) executive’s spouse sells 20,000 shares under 10b5-1 plan - Stock Titan
Tempus Q2 Earnings Call Highlights Data Growth and Pricing Upside - The Globe and Mail
Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance - The Next Web
Tempus AI (NASDAQ:TEM) Trading 7.5% HigherStill a Buy? - MarketBeat
Top Artificial Intelligence Stocks To Add to Your WatchlistAugust 10th - MarketBeat
Tempus AI, Inc. (TEM) Stock Analysis: 20.35% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Finivi Inc. Sells 24,340 Shares of Tempus AI, Inc. $TEM - MarketBeat
Tempus AI Inc (TEM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Tempus AI Stock (TEM) Opinions on Analyst Ratings and Portfolio Holdings - Quiver Quantitative
TEM Surges Into $1.5B MRD Deal As Stock Pulls Back - StocksToTrade
Why Tempus AI (TEM) Is Up 18.6% After Joining CellCarta’s CDx Commercialization Lab Network - simplywall.st
Tempus AI Stock Drops As $1.5B Personalis Deal Ups The MRD Stakes - StocksToTrade
Tempus AI, Inc. • Robinhood Token (TEM) Price Prediction for 2026 to 2031 - Bybit
Terra Environmental (TEM): Vanessa Kubo plans $922K stock sale, details 10b5-1 trades - Stock Titan
Tempus AI, Inc. • Robinhood Token Price: TEM/USD Live Price Chart, Market Cap & News Today - CoinGecko
Why Is Tempus AI Stock Surging on Friday? - Benzinga
Spotlight On Tempus AI And 2 Other Leading Insider-Owned Growth Stocks - webull.com
Tempus Hub Will Support Oncology Test Orders in CellCarta Deal - Stock Titan
Tempus AI Insider Sold Shares Worth $1,100,076, According to a Recent SEC Filing - marketscreener.com
Tempus AI (NASDAQ:TEM) Director David Epstein Sells 370 Shares of Stock - MarketBeat
Insider Selling: Tempus AI (NASDAQ:TEM) CEO Sells 23,818 Shares - MarketBeat
Tempus AI, Inc. (TEM) director sells 370 shares under 10b5-1 plan - Stock Titan
Piper Sandler Keeps Their Hold Rating on Tempus AI, Inc. Class A (TEM) - theglobeandmail.com
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications - Business Wire
Tempus AI, Inc. Stock 12‑Month Price Target Cut to $62.21, Implies 42% Upside - TradingView
Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 48% Potential Upside - DirectorsTalk Interviews
BTIG cuts Tempus AI stock price target to $70 on model update - Investing.com
Tempus AI Inc : JP Morgan Cuts Target Price t - moomoo.com
Tempus AI Stock (TEM) Opinions on Recent Trading Activity and Corrections - Quiver Quantitative
InvestingPro spotted Tempus AI’s 43% decline 7 months in advance By Investing.com - Investing.com
Avidity Partners Management LP Purchases New Stake in Tempus AI, Inc. $TEM - MarketBeat
The Bull Case For Tempus AI (TEM) Could Change Following Profit Return, Outlook Hike And Personalis DealLearn Why - simplywall.st
Tempus AI (TEM) awards 40,000 RSUs to EVP and Chief Legal Officer - Stock Titan
Tempus AI, Inc. (TEM) awards 40,000 RSUs to CFO James Rogers - Stock Titan
Tempus AI, Inc. Stock 12‑Month Price Target Cut to $66.07, Implies 49% Upside - TradingView
Tempus AI Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Tempus Ai Insider Sold Shares Worth $10,514,914, According to a Recent SEC Filing - marketscreener.com
Tempus AI Q2 Earnings Call Highlights - MarketBeat
Tempus AI, Inc. Revises Earnings Guidance for the Full Year 2026 - marketscreener.com
Dear Tempus AI Stock Fans, Mark Your Calendars for July 30 - Barchart.com
Tempus AI buys Personalis to strengthen AI-driven cancer monitoring platform - Mugglehead Investment Magazine
Tempus AI (NASDAQ:TEM) Hits New 52-Week LowTime to Sell? - MarketBeat
2.29%
3.39%
자본화:
|
볼륨(24시간):